TrialCancer immunology, immunotherapy : CII2014

Interleukin-2-stimulated natural killer cells are less susceptible to mycophenolate mofetil than non-activated NK cells: possible consequences for immunotherapy.

Claudia Brehm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.